ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979